Sorafenib Prevents Escape from Host Immunity in Liver Cirrhosis Patients with Advanced Hepatocellular Carcinoma

Purpose. It has been reported that Th2 cytokines downregulate antitumor immunity, while activation of type T cells promotes antitumor immunity. The aim of this paper was to evaluate host immunity in liver cirrhosis (LC) patients with advanced hepatocellular carcinoma (aHCC) receiving sorafenib thera...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Nagai, Hidenari, Mukozu, Takanori, Matsui, Daigo, Kanekawa, Takenori, Kanayama, Masahiro, Wakui, Noritaka, Momiyama, Kouichi, Shinohara, Mie, Iida, Kazunari, Ishii, Koji, Igarashi, Yoshinori, Sumino, Yasukiyo
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hindawi Publishing Corporation 2012
Soggetti:
Clinical Study
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3359796/
https://ncbi.nlm.nih.gov/pubmed/22666283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/607851
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi